This statement is made pursuant to section 54 of the Modern Slavery Act 2015 (the Act) and outlines steps taken by XVIVO Perfusion AB and its subsidiaries (together, ‘XVIVO’ or ‘the XVIVO Group’) to prevent modern slavery and human trafficking in our own operations and supply chain.
This statement relates to the financial year from 1 January 2024 to 31 December 2024 and covers the activities of XVIVO Perfusion AB (‘the parent entity’) and the following subsidiaries within the XVIVO group: XVIVO BV and XVIVO Perfusion Inc.
The Board of Directors of XVIVO Perfusion AB approved this statement on 10 December 2024.
XVIVO’s technologies and services enable clinicians and researchers around the world to preserve, transport and assess organs outside the body. Operating in the medical technology sector, XVIVO employs approximately 180 employees and has sales in more than 70 countries. XVIVO is headquartered in Gothenburg, Sweden and the parent company, XVIVO Perfusion AB, is listed on Nasdaq Stockholm. For more information about XVIVO, please visit: https://www.xvivogroup.com/about-us/.
XVIVO’s operations are conducted in three business areas: Thoracic (lung and heart transplantation), Abdominal (liver and kidney transplantation and perfusion services) and Services (organ recovery). Key operations include corporate functions in offices in Sweden, the Netherlands, Italy and the US; product development; and manufacturing and warehousing.
Product development primarily takes place in-house at XVIVO’s four global development centres: Gothenburg, Sweden (solutions); Lund, Sweden (heart); Groningen, Netherlands (kidney and liver); Denver, US (lung). Inhouse manufacturing and warehousing operations are located in the US, the Netherlands and Sweden.
XVIVO’s products are largely manufactured externally by carefully selected subcontractors. XVIVO’s manufacturing partners (tier 1 suppliers) are based in the US, Netherlands, Sweden, Switzerland and Germany. Specific parts for XVIVO’s products are sourced from a supplier based in China (tier 2). Other indirect suppliers in XVIVO’s value chain include those providing services and raw materials to our suppliers.
XVIVO has not yet undertaken a formal risk assessment relating to modern slavery or human trafficking in its business or supply chain, however we intend to do so in the next year. All countries where XVIVO has significant operations and all our manufacturing partners’ countries of operation are considered low risk for slavery, according to the Global Slavery Index 2023.[1]
XVIVO’s Code of Conduct sets out our commitment to upholding high ethical standards in compliance with all applicable laws and regulations. This means acting in accordance with ethical guidelines and international instruments, including the UN Universal Declaration of Human Rights, the ILO Fundamental Principles and Rights at Work, the UN Global Company and the OECD Guidelines for Multinational Enterprises.
XVIVO prohibits the use of forced and child labour within its own operations and by its business partners. The Code applies to all XVIVO employees and temporary employees and XVIVO’s management oversees compliance with the CEO ultimately responsible. The Code of Conduct can be found at: https://www.xvivogroup.com/about-us/business-ethics-2/.
All suppliers are expected to meet minimum ethical requirements within their own operations and their supply chain, as set out in XVIVO’s Code of Conduct for Suppliers (‘the Supplier Code’).
The Code of Conduct for Suppliers is aligned with international human rights instruments and contains provisions relating to ethical labour practices. The Supplier Code prohibits suppliers from using any form of forced labour and requires suppliers establish mechanisms to implement and communicate its principles within its supply chain. XVIVO reserves the right to request information relating to the provisions of the Supplier Code and may conduct audits and reviews of suppliers. The Strategic Sourcing Director is responsible for the implementation of the Code of Conduct for Suppliers.
XVIVO’s Code of Conduct for Suppliers can be found at: https://www.xvivogroup.com/about-us/business-ethics/code-of-conduct-for-suppliers/.
With 25 years’ experience in the industry, XVIVO has built close partnerships with key suppliers, who are expected to meet high quality and ethical standards. These activities collectively contribute to mitigating the risk of modern slavery within XVIVO’s operations and supply chains.
All critical suppliers must align with the requirements set out in the Code of Conduct for Suppliers or equivalent ethical principles. XVIVO evaluates and selects major suppliers and subcontractors on their ability to meet the principles outlined in its overarching Code of Conduct. XVIVO also requires that all distributors abide by the overarching Code of Conduct, which is attached to the Distributor Agreements.
XVIVO will support suppliers to meet ethical requirements through dialogue and co-operation. Suppliers who do not meet the principles of the Supplier Code or equivalent must discuss corrective actions with XVIVO. The Strategic Sourcing Director is ultimately responsible for overseeing supplier due diligence.
All employees and external stakeholders can report violations of the Code of Conduct or unlawful behaviour confidentially through XVIVO’s external whistleblower function. This can be accessed through XVIVO’s website: https://www.xvivogroup.com/.
XVIVO tracks the number of cases raised through its whistleblowing function. All reported cases are tracked and investigated. Where an ethical or legal violation is found to have taken place, XVIVO will take corrective measures. More information on whistleblowing cases is reported in XVIVO’s annual reporting which is available at: https://www.xvivogroup.com/investors/reports-and-presentations/
All XVIVO employees receive business conduct training to ensure all staff understand the behavioural standards expected of them. At present, Modern Slavery is implicitly rather than explicitly addressed as part of this training, which covers XVIVO’s Code of Conduct.
XVIVO acknowledges that effective due diligence is an ongoing process. XVIVO intends to review its due diligence processes and practices, as well as its training practices with respect to modern slavery, based on the outcome of its modern slavery risk assessment.
Christoffer Rosenblad
CEO
XVIVO Perfusion AB
Date: 9 January 2025